Navigation Links
Ad de Waard Appointed Vice President of International Sales and Marketing at Accumetrics, Inc.
Date:12/16/2008

SAN DIEGO, Dec. 16 /PRNewswire/ -- Accumetrics, Inc. has appointed 20-year industry veteran Ad de Waard as Vice President of International Sales and Marketing.

"Ad joins us at an important juncture in the evolution of Accumetrics, as we are now well-positioned to expand our international business," says Timothy I. Still, President and CEO at Accumetrics. "His extensive experience in managing global distribution networks will be invaluable as we continue on our growth path and expand our capabilities to provide Accumetrics' products to customers worldwide."

Mr. de Waard has more than 20 years' experience in the in-vitro diagnostics industry in roles of increasing responsibility involving international sales and marketing and general management. He has launched several new cardiovascular products, including products in the area of platelet function analysis.

Prior to Accumetrics, Mr. de Waard served as Director of International Business Development at Inverness, Inc., which acquired HemoSense, Inc. in 2007. Prior to his time at HemoSense, he held various international marketing positions, including those at Dade Behring and Amersham International. In his new position at Accumetrics, Mr. de Waard will be based in the Netherlands.

Mr. de Waard holds several degrees and certificates, including his HBO (the Dutch equivalent of a bachelor degree) from the School of Clinical Chemistry, The Netherlands, MBO certificates in process chemistry and electrotechnology, and completion of the marketing program at the Netherlands Institute of Marketing.

AboutAccumetrics(www.accumetrics.com)

Accumetrics is committed to advancing medical understanding of platelet function and enhancing quality of care for patients receiving antiplatelet therapies by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment.

Accumetrics' VerifyNow(R) System is the first rapid and easy to use platform for measuring an individual's response to multiple antiplatelet agents. Addressing every major antiplatelet drug, including FDA-cleared products for aspirin, Plavix(R), ReoPro(R), and Integrilin(R), the VerifyNow System provides a valuable tool to help physicians make informed treatment decisions.

The Accumetrics logo and VerifyNow are registered trademarks of Accumetrics, Inc. ReoPro is a registered trademark of Centocor, Inc. Integrilin is a registered trademark of Millennium Pharmaceuticals. Plavix is a registered trademark of Sanofi-Aventis.

    CONTACT:  Jules Abraham
              Lippert Heilshorn & Associates
              212-838-3777
              jabraham@lhai.com

              Timothy I. Still
              Accumetrics
              press@accumetrics.com


'/>"/>
SOURCE Accumetrics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Dr. Allen Woolf Appointed Chief Medical Officer For CIGNA Group Insurance
2. William Moore Appointed to IRIDEX Board of Directors
3. Roy Jakobs Appointed Elsevier Managing Director, A&G Sales and Customer Marketing
4. Katie Hood Appointed Interim Chief Executive Officer of Michael J. Fox Foundation
5. James B. Hawkins Appointed to IRIDEX Board of Directors
6. Bryan R. Rogers Appointed President of Far West Division
7. Theodore A. Boutacoff Appointed President & CEO of IRIDEX
8. Catholic Health Association Disappointed by Failure to Override SCHIP Veto
9. Steven M. Safyer, MD, Appointed President and CEO of Montefiore Medical Center
10. Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technologies, Inc.
11. Irene Hegeman Richard, MD, Appointed Senior Medical Advisor to The Michael J. Fox Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... Maury Regional Health has announced a large-scale ... broadly deploying AccuVein devices, Maury Regional Medical Center is making vein visualization part of ... a needle stick and more importantly, helps our staff members locate a vein that ...
(Date:8/16/2017)... ... August 16, 2017 , ... With a new PD diagnosis every nine minutes, ... , The grants are awarded through a competitive application process and reviewed by APDA’s ... backgrounds and expertise in all areas relevant to PD research. The SAB meets ...
(Date:8/16/2017)... , ... August 16, 2017 , ... ... $5.99, eBook, 9781498499620    ) shares that during the time of a cancer diagnosis, surgery ... of God's love, and all the many ways God shows love to those ...
(Date:8/16/2017)... Lake Orion, Rochester, Michigan (PRWEB) , ... August ... ... now offer treatment options to patients suffering from chronic pelvic pain. In ... treatment of various pelvic pain disorders including endometriosis, menorrhagia (abnormal heavy bleeding during ...
(Date:8/16/2017)... ... August 16, 2017 , ... With low back pain afflicting 8 of 10 Americans at ... kissing cousin – upper back pain. But this equally vexing condition stems from a variety ... Kaixuan Liu, MD, PhD , founder and president of Atlantic Spine Center. , ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO), is now ... residents. Naloxone is available without a ... pharmacy, G-3320 Beecher Road. ... Administration, is intended to block or reverse the effects ... of consciousness. The medication is often carried by first ...
(Date:8/11/2017)... Israel , Aug. 11, 2017 DarioHealth ... with mobile health and big data solutions, today announced ... on Monday, August 14 and host a conference call ... quarter 2017 operating and financial results and its strategy ... will be hosted by Erez Raphael , Chief ...
(Date:8/7/2017)... WARSAW, Ind. , Aug. 7, 2017 Zimmer ... in musculoskeletal healthcare, today announced that its Board of Directors ... stockholders for the third quarter of 2017. ... will be paid on or about October 27, 2017 to ... September 22, 2017.  Future declarations of dividends are subject to ...
Breaking Medicine Technology: